NGL Fine-Chem informs about disclosure

19 Aug 2024 Evaluate
Pursuant to Regulation 30 the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, NGL Fine-Chem has informed that the Company has received Certificate of suitability No. CEP 2022-160 - Rev 00, from European Directorate for the Quality of Medicines & Healthcare (EDQM) for its product FLUNIXIN MEGLUMINE. This certificate facilitates registration and use of FLUNIXIN MEGLUMINE manufactured by the company by the European customers for their finished product.

The above information is a part of company’s filings submitted to BSE.

NGL Fine-Chem Share Price

1058.40 -21.60 (-2.00%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...